Analyst Reco. Ocular Therapeutix, Inc.

Equities

OCUL

US67576A1007

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
4.745 ^USD	+12.98%		-9.10%	+6.39%

Apr. 18	Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup	DJ
Apr. 18	Ocular Therapeutix Reports Positive Topline Data in Diabetic Retinopathy Trial; Shares Fall	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Ocular Therapeutix to $15 From $12, Keeps Buy Rating	Mar. 13	MT
TD Cowen Adjusts Price Target on Ocular Therapeutix to $11 From $8, Maintains Market Perform Rating	Mar. 12	MT
JMP Securities Adjusts Ocular Therapeutix's Price Target to $24 From $12, Maintains Market Outperform Rating	Mar. 12	MT
Piper Sandler Adjusts Ocular Therapeutix Price Target to $15 From $10, Maintains Overweight Rating	Feb. 26	MT
HC Wainwright Adjusts Ocular Therapeutix Price Target to $12 From $10, Maintains Buy Rating	23-06-13	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $11, Maintains Buy Rating	23-05-09	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix to $12 From $11, Keeps Market Outperform Rating	23-05-09	MT
Baird Initiates Ocular Therapeutix at Outperform With $18 Price Target	23-04-21	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix to $11 From $12, Maintains Market Outperform Rating	23-03-07	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $11 From $9, Maintains Buy Rating	23-02-14	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix's to $12 From $25, Maintains Market Outperform Rating	23-01-09	MT
Raymond James Adjusts Price Target on Ocular Therapeutix to $14 From $29, Maintains Strong Buy Rating	22-11-08	MT
HC Wainwright Trims Price Target on Ocular Therapeutix to $9 From $10, Maintains Buy Rating	22-11-08	MT
Berenberg Bank Assumes Coverage on Ocular Therapeutix With Buy Rating, $15 Price Target	22-08-10	MT
JMP Securities Adjusts Ocular Therapeutix Price Target to $25 From $20, Maintains Market Outperform Rating	22-08-09	MT
Jefferies Raises Price Target for Ocular Therapeutix to $6.50 From $5, Maintains Buy Rating	22-08-09	MT
Berenberg Bank Suspends Coverage of 25 Companies in Consumer Discretionary, Healthcare, Industrial Tech, and Software Sectors	22-07-01	MT
Piper Sandler Adjusts Price Target on Ocular Therapeutix to $10 From $16, Reiterates Overweight Rating	22-05-31	MT
Berenberg Bank Cuts Price Target on Ocular Therapeutix to $21 From $23, Maintains Buy Rating	22-05-11	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $14, Reiterates Buy Rating	22-05-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Ocular Therapeutix, Inc.

Equities

OCUL

US67576A1007

Analyst Reco.

Filters